drugset / Trial / NCT00343811

Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment

NCT00343811

Phase 3 Completed 120 enrolled Cephalon
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the continued efficacy of modafinil treatment, compared to placebo treatment, in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) who are responders to modafinil treatment.

Timeline

Start
2006-06
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule